Carl D. Sjostrom - Publications

Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial.

Journal: Lancet (London, England)

Published: March 09, 2026

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.

Journal: Diabetes, obesity & metabolism

Published: January 20, 2026

New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomes.

Journal: Kidney international

Published: January 13, 2026

A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 24, 2025

Time to modernise healthcare regarding functional disorders

Journal: Lakartidningen

Published: September 25, 2025

Protein profiles and associated biological pathways among different etiologies of chronic kidney disease: new insights from DAPA-CKD.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 08, 2025

Effects of Dapagliflozin on Progression of CKD According to Different Rates of Pretrial eGFR Loss.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: May 09, 2025

Protein profiles and associated biological pathways among different aetiologies of chronic kidney disease: new insights from DAPA-CKD.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 18, 2025

Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial.

Journal: JAMA cardiology

Published: August 14, 2024

Baseline, Early Changes, and Residual Albuminuria: Post Hoc Analysis of a Randomized Clinical Trial of Dapagliflozin in Chronic Kidney Disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 19, 2024

Functional neurological disorder in Europe: regional differences in education and health policy.

Journal: European journal of neurology

Published: March 07, 2024

The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: November 08, 2023